Armenia vs Russian Federation: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Armenia
94.0%
in 2024
Russian Federation
94.0%
in 2024
Armenia rank
34th
Russian Federation rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Armenia
- Russian Federation
How they compare
Armenia currently reports 94.0% against 94.0% in Russian Federation, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Armenia ahead.
Armenia ranks 34th and Russian Federation ranks 34th of 146 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.0% | 67.8% | 25.2% | Armenia |
| 2020s | 93.2% | 91.0% | 2.2% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Armenia or Russian Federation?
- Armenia, at 94.0% against 94.0% in Russian Federation as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Armenia and Russian Federation?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Russian Federation?
- 9 years are reported by both, from 2016 to 2024.
- How do Armenia and Russian Federation rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Armenia ranks 34th and Russian Federation ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.